Amikacin impurities

Amikacin impurities arise from synthetic pathway deviations or oxidative cleavage of the parent aminoglycoside's 2-deoxystreptamine core, resulting in altered glycosidic linkages or amino sugar substitutions. Key structural features include modified hydroxyl group positioning at C-4' and C-5' of the aminocyclitol ring, coupled with variable acetylation patterns on the amino sugar moieties. This impurity class exhibits reduced antibacterial activity due to disrupted hydrogen bonding capabilities. Analytically, it serves as an HPLC reference standard for quantifying process-related impurities in amikacin sulfate formulations.